Baxter Ventures and Harvard University Launch Opsonix with $8 Million in Series A Funding
Turing Pharma CEO Martin Shkreli Looks to Make Over Image, Hires Washington Lobbyists
THERAMetrics (TMX.SW) Undergoes Radical Restructuring in Effort to Avoid Bankruptcy
Sanofi (SNY) Boss Prepares for Battle with French Unions; Pushes for Longer Hours, Cuts Vacation Days
Analysts Closely Watch Bay Area CytomX's $80 Million IPO
Eli Lilly (LLY) Gains FDA Breakthrough Therapy Designation for Abemaciclib
Sanofi Genzyme (SNY) Touts Long-Term Data for Multiple Sclerosis Drug Lemtrada
Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Technology
Neurocrine Biosciences (NBIX)'s NBI-98854 Hits Primary Enpoint in Phase III Study
MD Anderson Cancer Center and Theraclone Launch New Immuno-Oncology Company OncoResponse with $10 Million Series A
Death Forces FDA to Place Clinical Hold on Advaxis (ADXS) Cancer Drug
Amgen (AMGN) Fights Fire with Fire in the Biosimilars Market
Best Cities, States and Pay for Medical Sales Job
Valeant (VRX) Fires Back at Critics, Supported by Investor Bill Ackman
Express Scripts to Cover Amgen (AMGN), Regeneron (REGN)'s Pricey New Cholesterol Drugs
Clal Biotech (CLALF) Opts Out of Re-Acquiring Andromeda from Hyperion (HPTX) After Phase III Diabetes Drug Tanks
Cambridge Startup Quartet Medicine Bags $23.25 Million Series A Financing
Genocea Biosciences (GNCA)'s GEN-003 Meets Primary Endpoint In Phase II Genital Herpes Trial
See All News >